Analyzing the relationship between gut bacteria and immune response in patients with a specific type of dermatomyositis and lung disease
Official title: Microecology and Host Immunity in Patients With Anti-melanoma Differentiation Associated Gene 5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
Run by Chinese PLA General Hospital · NCT06203249 · Data updated 2026-11-12
This study is trying to see how the bacteria in the gut affect the immune system in patients with a specific type of skin and lung disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Chinese PLA General Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | January 20, 2024 |
| Main results expected | December 30, 2025 |
| Study ends | November 25, 2026 |
| Registry record updated | January 12, 2024 |
| Trial ID | NCT06203249 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been diagnosed with anti-MDA5 antibody positive dermatomyositis and rapidly progressive interstitial lung disease.
✕Probably not a fit
Patients with other connective tissue diseases or those whose interstitial lung disease is caused by infections, tumors, or other factors may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate how the microbial community in the body interacts with the immune system in patients who have anti-MDA5 antibody positive dermatomyositis and concurrent rapidly progressive interstitial lung disease. Researchers will collect bronchoalveolar lavage specimens from these patients to analyze the composition of their microecology and its potential impact on disease progression. The study focuses on understanding the connection between microbiome diversity and immune function in this specific patient population.
Why it matters
Potential benefit: If successful, this study could lead to new insights into the treatment and management of dermatomyositis and interstitial lung disease by targeting microbiome-related factors.
How similar studies have gone: While the specific approach of this study may be novel, similar studies investigating the microbiome's role in autoimmune diseases have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who meet the diagnostic criteria of dermatomyositis and anti-MDA 5 antibody positive. * Anti-MDA5 antibody positive DM patients with RPILD meet the diagnostic criteria for RPILD. * Must have undergone bronchoalveolar lavage. * Age≥18 years old. * Patients who signed informed consent forms Exclusion Criteria: * Patients who had other connective tissue diseases. * Patients with ILD or RPILD caused by infection, tumors, drugs, biochemistry and other factors. * Pregnant or lactating patients. * The patient also participated in any other clinical trial. * Disagreement for inclusion in this study
Where it's running
-
Pla
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Zhimei Duan, doctor
- Email: 549117002@qq.com
- Phone: 13716376758
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Egg intake and gut health, HDL, and immune markers in adults
This study tests whether daily egg whites or whole eggs affect gut microbiome, HDL function, metabolism, and immune profiles in adults with a range of BMIs.
-
Daily yogurt to support immune function in healthy adults
Healthy adults will try daily yogurt or a placebo for 8 weeks to see if it affects saliva immune markers and how they feel.
-
Laparoscopic removal of splenic artery aneurysm with spleen preservation
This study tries a minimally invasive laparoscopic operation that removes splenic artery aneurysms while saving the spleen in patients with aneurysms that are large, ruptured, or growing quickly, and checks immune function and nearby blood flow over a year.
-
Effects of a 48-hour fast with or without exercise on immune function and blood sugar control
This study is testing how a 48-hour fast, with and without exercise, affects the immune system and blood sugar levels in healthy, active adults.
-
Ketone supplement to improve strength and wellbeing in older adults with mild frailty
This study tests whether taking a daily ketone ester supplement for 20 weeks can help people aged 65 and older with slight declines in physical function become stronger and feel healthier.
-
Mobile intervention to promote clean cooking fuel use in Bangladesh
This study is testing a mobile phone program to see if it can encourage households in Bangladesh to switch to cleaner cooking fuel, like Liquid Petroleum Gas, to improve their health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.